Global and United States Rhabdomyosarcoma Drug Market Research by Company, Type & Application 2013-2025

Publisher Name :
Date: 10-Jul-2018
No. of pages: 152

Summary

Market Segment as follows:

By Type

ARI-4175

Celyvir

Crizotinib

Enoblituzumab

AT-69

Axitinib

Others

By Application

Research Center

Hospital

Clinic

Others

By Company

Bellicum Pharmaceuticals Inc

Boehringer Ingelheim GmbH

Bristol-Myers Squibb Co

Celgene Corp

Eisai Co Ltd

Epizyme Inc

Exelixis Inc

Iproteos SL

Ipsen SA

MacroGenics Inc

NantKwest Inc

Novartis AG

Noxxon Pharma AG

Pfizer Inc

Taiho Pharmaceutical Co Ltd

Taiwan Liposome Company Ltd

Tarveda Therapeutics Inc

The main contents of the report including:

Section 1:

Product definition, type and application, global and United States market overview;

Section 2:

Global and United States Market competition by company;

Section 3:

Global and United States sales revenue, volume and price by type;

Section 4:

Global and United States sales revenue, volume and price by application;

Section 5:

United States export and import;

Section 6:

Company information, business overview, sales data and product specifications;

Section 7:

Industry chain and raw materials;

Section 8:

SWOT and Porter's Five Forces;

Section 9:

Conclusion.

Global and United States Rhabdomyosarcoma Drug Market Research by Company, Type & Application 2013-2025

Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 ARI-4175
1.1.2.2 Celyvir
1.1.2.3 Crizotinib
1.1.2.4 Enoblituzumab
1.1.2.5 AT-69
1.1.2.6 Axitinib
1.1.2.7 Others
1.1.3 Market by Application
1.1.3.1 Research Center
1.1.3.2 Hospital
1.1.3.3 Clinic
1.1.3.4 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 Regional Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Bellicum Pharmaceuticals Inc
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Boehringer Ingelheim GmbH
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Bristol-Myers Squibb Co
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Celgene Corp
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eisai Co Ltd
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Epizyme Inc
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Exelixis Inc
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Iproteos SL
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Ipsen SA
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 MacroGenics Inc
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 NantKwest Inc
6.12 Novartis AG
6.13 Noxxon Pharma AG
6.14 Pfizer Inc
6.15 Taiho Pharmaceutical Co Ltd
6.16 Taiwan Liposome Company Ltd
6.17 Tarveda Therapeutics Inc
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion

List of Tables

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Bellicum Pharmaceuticals Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Boehringer Ingelheim GmbH
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Co
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corp
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai Co Ltd
Table Sales Revenue, Volume, Price, Cost and Margin of Epizyme Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Exelixis Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Iproteos SL
Table Sales Revenue, Volume, Price, Cost and Margin of Ipsen SA
Table Sales Revenue, Volume, Price, Cost and Margin of MacroGenics Inc
Table Sales Revenue, Volume, Price, Cost and Margin of NantKwest Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Table Sales Revenue, Volume, Price, Cost and Margin of Noxxon Pharma AG
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Taiho Pharmaceutical Co Ltd
Table Sales Revenue, Volume, Price, Cost and Margin of Taiwan Liposome Company Ltd
Table Sales Revenue, Volume, Price, Cost and Margin of Tarveda Therapeutics Inc


List of Figures

Figure ARI-4175 Market Size and CAGR 2013-2017 (Million USD)
Figure ARI-4175 Market Size and CAGR 2013-2017 (Volume)
Figure ARI-4175 Market Forecast and CAGR 2018-2025 (Million USD)
Figure ARI-4175 Market Forecast and CAGR 2018-2025 (Volume)
Figure Celyvir Market Size and CAGR 2013-2017 (Million USD)
Figure Celyvir Market Size and CAGR 2013-2017 (Volume)
Figure Celyvir Market Forecast and CAGR 2018-2025 (Million USD)
Figure Celyvir Market Forecast and CAGR 2018-2025 (Volume)
Figure Crizotinib Market Size and CAGR 2013-2017 (Million USD)
Figure Crizotinib Market Size and CAGR 2013-2017 (Volume)
Figure Crizotinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Crizotinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Enoblituzumab Market Size and CAGR 2013-2017 (Million USD)
Figure Enoblituzumab Market Size and CAGR 2013-2017 (Volume)
Figure Enoblituzumab Market Forecast and CAGR 2018-2025 (Million USD)
Figure Enoblituzumab Market Forecast and CAGR 2018-2025 (Volume)
Figure AT-69 Market Size and CAGR 2013-2017 (Million USD)
Figure AT-69 Market Size and CAGR 2013-2017 (Volume)
Figure AT-69 Market Forecast and CAGR 2018-2025 (Million USD)
Figure AT-69 Market Forecast and CAGR 2018-2025 (Volume)
Figure Axitinib Market Size and CAGR 2013-2017 (Million USD)
Figure Axitinib Market Size and CAGR 2013-2017 (Volume)
Figure Axitinib Market Forecast and CAGR 2018-2025 (Million USD)
Figure Axitinib Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Research Center Market Size and CAGR 2013-2017 (Million USD)
Figure Research Center Market Size and CAGR 2013-2017 (Volume)
Figure Research Center Market Forecast and CAGR 2018-2025 (Million USD)
Figure Research Center Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospital Market Size and CAGR 2013-2017 (Million USD)
Figure Hospital Market Size and CAGR 2013-2017 (Volume)
Figure Hospital Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospital Market Forecast and CAGR 2018-2025 (Volume)
Figure Clinic Market Size and CAGR 2013-2017 (Million USD)
Figure Clinic Market Size and CAGR 2013-2017 (Volume)
Figure Clinic Market Forecast and CAGR 2018-2025 (Million USD)
Figure Clinic Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Million USD)
Figure Global Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Volume)
Figure Global Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Million USD)
Figure United States Rhabdomyosarcoma Drug Market Size and CAGR 2013-2017 (Volume)
Figure United States Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Rhabdomyosarcoma Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Rhabdomyosarcoma Drug SWOT List
Figure Life & Medical Porter's Five Forces
  • Global Cytotoxic Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Jul-2018        Price: US 3480 Onwards        Pages: 136
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. Scope of th......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cytotoxic Drug Market 2018, Forecast to 2023
    Published: 17-Jul-2018        Price: US 4880 Onwards        Pages: 132
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. Scope of th......
  • Global Lentinan Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Jul-2018        Price: US 3480 Onwards        Pages: 133
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. Scope of the Report: This report focuses on the Lentinan in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. As an intravenous biological response modifier, l......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Lentinan Market 2018, Forecast to 2023
    Published: 16-Jul-2018        Price: US 4880 Onwards        Pages: 129
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. Scope of the Report: This report focuses on the Lentinan in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. As an intravenous biological response modifier, l......
  • Global and United States Oncology Drugs Market Research by Company, Type & Application 2013-2025
    Published: 13-Jul-2018        Price: US 2000 Onwards        Pages: 122
    Summary Market Segment as follows: By Type - Oral Therapy - Injectable Therapy By Application - Targeted Therapy - Chemotherapy - Hormonal Therapy - Biologic Therapy By Company - Novartis A.G - Laboratrio Cristlia - Medley Genomics - F. Hoffmann-La Roche Ltd - Icon Plc. - Sanofi S.A. - Laboratoires Pierre Fabre - Eurofarma Laboratrios S.A. - Ach Laboratrios Farmacu......
  • Global and United States Hydroxycarbamide Market Research by Company, Type & Application 2013-2025
    Published: 08-Jul-2018        Price: US 2000 Onwards        Pages: 119
    Summary Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Market Segment as follows: By Type - Capsule - Tablet By Application - Sickle Cell Disease - Cancer - Others By Company - Taj Pharma - Bristol......
  • 2018-2023 Global Lentinan Consumption Market Report
    Published: 05-Jul-2018        Price: US 4660 Onwards        Pages: 137
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Lentinan market for 2018-2023. Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side ef......
  • 2018 Top 5 Lentinan Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 05-Jul-2018        Price: US 4960 Onwards        Pages: 127
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan's efficacy, its market size has been limite......
  • 2013-2023 Global Myelodysplastic Syndrome Drug Industry Report
    Published: 05-Jul-2018        Price: US 4000 Onwards        Pages: 141
    The global market size of Myelodysplastic Syndrome Drug is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This repor......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs